CYP19A1 and breast cancer: As melatonin treatment prior to radiotherapy sensitizes breast cancer cells to radiation by downregulating DNA repair and promoting cell cycle arrest, p53 upregulation and consequent aromatase downregulation might represent the link between melatonin and its radiation-sensitizing effect on breast cancer cells.